Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) (2020)

Cho, Jang Ho; Lim, Sung Hee; An, Ho Jung; Kim, Ki Hwan; Park, Keon Uk; Kang, Eun Joo; Choi, Yoon Hee; Ahn, Mi Sun; Lee, Myung Hee; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju

doi:10.1200/JCO.20.00446

Detailed Information

Cited 0 time in webofscience

Cited 0 time in scopus

Metadata Downloads

Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) (2020)

Authors: Cho, Jang Ho; Lim, Sung Hee; An, Ho Jung; Kim, Ki Hwan; Park, Keon Uk; Kang, Eun Joo; Choi, Yoon Hee; Ahn, Mi Sun; Lee, Myung Hee; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju

Issue Date: 10-Apr-2020

Publisher: AMER SOC CLINICAL ONCOLOGY

Citation: JOURNAL OF CLINICAL ONCOLOGY, v.38, no.11, pp.1248 - 1248

Indexed: SCIE
SCOPUS

Journal Title: JOURNAL OF CLINICAL ONCOLOGY

Volume: 38

Number: 11

Start Page: 1248

End Page: 1248

URI: https://scholar.korea.ac.kr/handle/2021.sw.korea/56633

DOI: 10.1200/JCO.20.00446

ISSN: 0732-183X

Files in This Item: There are no files associated with this item.

Appears in Collections: College of Medicine > Department of Medical Science > 1. Journal Articles

Show full item record

qrcode

Altmetrics

Total Views & Downloads

STATISTICS: Total View :6,906,736; Today View :5,753

RSS_1.0 RSS_2.0 ATOM_1.0

145 Anam-ro, Seongbuk-gu, Seoul, 02841, Korea+82-2-3290-2963

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Altmetrics

Total Views & Downloads

BROWSE